- Azenta enters exclusive licensing agreement with Elegen and acquires SynPlexity.
- Investments are aimed at expanding high-throughput gene synthesis discovery workflows.
- Financial terms were not immediately disclosed in the filing summary.
?? Positive AI Sentiment (+2.5 / 10)